Urte Gayko - 25 Apr 2022 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Director
Signature
/s/ Urte Gayko
Issuer symbol
SMMT
Transactions as of
25 Apr 2022
Net transactions value
$0
Form type
4
Filing time
26 Apr 2022, 16:36:58 UTC
Previous filing
05 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SMMT Stock Option (right to buy) Award +400,000 400,000 25 Apr 2022 Common Stock 400,000 $1.93 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on April 25, 2022. The shares underlying the option are scheduled to vest in four equal annual installments over four years.
F2 Not applicable.